SurModics/SRDX

$32.07

0.53%
-
1D1W1MYTD1YMAX

About SurModics

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Ticker

SRDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Gary Maharaj

Employees

376

Headquarters

Eden prairie, United States

SurModics Metrics

BasicAdvanced
$456.55M
Market cap
82.00
P/E ratio
$0.39
EPS
1.02
Beta
-
Dividend rate

What the Analysts think about SurModics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
83.97% upside
High $75.00
Low $44.00
$32.07
Current price
$59.00
Average price target

SurModics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2.29% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$30.5M
9.32%
Net income
$-700K
-110.61%
Profit margin
-2.29%
-109.68%

SurModics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 186.49%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.40
$0.52
$0.53
-
-
Expected
-$0.51
$0.05
$0.19
-$0.30
-$0.32
Surprise
-21.31%
893.64%
186.49%
-
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell SurModics stock

Buy or sell SurModics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing